Fundz

Marksans Pharma acquires ABCnow GmbH for €892,384

Jul 08, 2026

Acquiring Company

Marksans Pharma

Acquired Company

ABCnow GmbH

MumbaiManufacturingBiotechnologyPharmaceutical

Description

Marksans Pharma has entered into a definitive agreement to acquire 100% of ABCnow GmbH for €892,384. This acquisition aims to enhance Marksans Pharma's presence in regulated European markets by utilizing ABCnow GmbH's sales and marketing infrastructure. The transaction is anticipated to be completed by July 31, 2026. The acquisition will support Marksans Pharma's growth aspirations in Europe.

Who to call at Marksans Pharma, and when

When Marksans Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Marksans Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Marksans Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Marksans Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Marksans Pharma

Location

Mumbai, Maharashtra, India

About

Marksans Pharma is a global pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical formulations. The company is focused on delivering high-quality products while expanding its market reach. With a strong presence in various international markets, it aims to enhance patient access to affordable medicines.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Marksans Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Vivek
Senior decision-maker at this company
••••••••@••••••••

See Vivek's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Marksans Pharma's next move

Learn about Strategic plan

Frequently asked

Who acquired ABCnow GmbH?

ABCnow GmbH was acquired by Marksans Pharma, based in Mumbai. The deal was reported on July 8, 2026. Marksans Pharma is a global pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical formulations. Marksans Pharma is privately held and operates in Manufacturing.

When did Marksans Pharma acquire ABCnow GmbH?

Marksans Pharma's acquisition of ABCnow GmbH was reported on July 8, 2026. Marksans Pharma has entered into a definitive agreement to acquire 100% of ABCnow GmbH for €892,384. This acquisition aims to enhance Marksans Pharma's presence in regulated European markets by utilizing ABCnow GmbH's sales and marketing infrastructure. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does ABCnow GmbH do?

ABCnow GmbH is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.